{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:51:57Z","timestamp":1790621517655,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CenturyLink"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10552-017-0929-4","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T07:21:25Z","timestamp":1501226485000},"page":"971-979","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma"],"prefix":"10.1007","volume":"28","author":[{"given":"Ellen T.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund C.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionna S.","family":"Mowat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jane","family":"Teta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"929_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminhematol.2016.05.008","volume":"53","author":"AK Ng","year":"2016","unstructured":"Ng AK, van Leeuwen FE (2016) Hodgkin lymphoma: late effects of treatment and guidelines for surveillance. Semin Hematol 53:209\u2013215","journal-title":"Semin Hematol"},{"key":"929_CR2","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E","volume":"67","author":"LB Travis","year":"1991","unstructured":"Travis LB, Curtis RE, Boice JD Jr, Hankey BF, Fraumeni JF Jr (1991) Second cancers following non-Hodgkin\u2019s lymphoma. Cancer 67:2002\u20132009","journal-title":"Cancer"},{"key":"929_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/cncr.21971","volume":"107","author":"JD Tward","year":"2006","unstructured":"Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK (2006) The risk of secondary malignancies over 30\u00a0years after the treatment of non-Hodgkin lymphoma. Cancer 107:108\u2013115","journal-title":"Cancer"},{"key":"929_CR4","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2008-10-184705","volume":"113","author":"ML Bruin De","year":"2009","unstructured":"De Bruin ML, Burgers JA, Baas P et al (2009) Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood 113:3679\u20133681","journal-title":"Blood"},{"key":"929_CR5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","volume":"25","author":"DC Hodgson","year":"2007","unstructured":"Hodgson DC, Gilbert ES, Dores GM et al (2007) Long-term solid cancer risk among 5-year survivors of Hodgkin\u2019s lymphoma. J Clin Oncol 25:1489\u20131497","journal-title":"J Clin Oncol"},{"key":"929_CR6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/cncr.22526","volume":"109","author":"MJ Teta","year":"2007","unstructured":"Teta MJ, Lau E, Sceurman BK, Wagner ME (2007) Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer 109:1432\u20131438","journal-title":"Cancer"},{"key":"929_CR7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.bjc.6605435","volume":"102","author":"A Berrington de Gonzalez","year":"2010","unstructured":"Berrington de Gonzalez A, Curtis RE, Gilbert E et al (2010) Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 102:220\u2013226","journal-title":"Br J Cancer"},{"key":"929_CR8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-007-9509-8","volume":"106","author":"LM Brown","year":"2007","unstructured":"Brown LM, Chen BE, Pfeiffer RM et al (2007) Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat 106:439\u2013451","journal-title":"Breast Cancer Res Treat"},{"key":"929_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.coc.0000256102.40842.78","volume":"30","author":"M Deutsch","year":"2007","unstructured":"Deutsch M, Land SR, Begovic M, Cecchini R, Wolmark N (2007) An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma. Am J Clin Oncol 30:294\u2013296","journal-title":"Am J Clin Oncol"},{"key":"929_CR10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"LB Travis","year":"2005","unstructured":"Travis LB, Fossa SD, Schonfeld SJ et al (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97:1354\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"929_CR11","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s10552-013-0230-0","volume":"24","author":"A Farioli","year":"2013","unstructured":"Farioli A, Violante FS, Mattioli S, Curti S, Kriebel D (2013) Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control 24:1535\u20131545","journal-title":"Cancer Causes Control"},{"key":"929_CR12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1379::AID-CNCR24>3.0.CO;2-Y","volume":"77","author":"A Cavazza","year":"1996","unstructured":"Cavazza A, Travis LB, Travis WD et al (1996) Post-irradiation malignant mesothelioma. Cancer 77:1379\u20131385","journal-title":"Cancer"},{"key":"929_CR13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/cam4.656","volume":"5","author":"A Farioli","year":"2016","unstructured":"Farioli A, Ottone M, Morganti AG et al (2016) Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database. Cancer Med 5:950\u2013959","journal-title":"Cancer Med"},{"key":"929_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0167-8140(96)01713-6","volume":"38","author":"I Diallo","year":"1996","unstructured":"Diallo I, Lamon A, Shamsaldin A, Grimaud E, de Vathaire F, Chavaudra J (1996) Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 38:269\u2013271","journal-title":"Radiother Oncol"},{"key":"929_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","volume":"65","author":"EJ Hall","year":"2006","unstructured":"Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65:1\u20137","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.HP.0000326342.47348.06","volume":"95","author":"JA Purdy","year":"2008","unstructured":"Purdy JA (2008) Dose to normal tissues outside the radiation therapy patient\u2019s treated volume: a review of different radiation therapy techniques. Health Phys 95:666\u2013676","journal-title":"Health Phys"},{"key":"929_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0971-6203.79686","volume":"36","author":"ML Taylor","year":"2011","unstructured":"Taylor ML, Kron T (2011) Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy. J Med Phys 36:59\u201371","journal-title":"J Med Phys"},{"key":"929_CR18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5<948::AID-CNCR17>3.0.CO;2-W","volume":"80","author":"AI Neugut","year":"1997","unstructured":"Neugut AI, Ahsan H, Antman KH (1997) Incidence of malignant pleural mesothelioma after thoracic radiotherapy. Cancer 80:948\u2013950","journal-title":"Cancer"},{"key":"929_CR19","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","volume":"373","author":"M Schaapveld","year":"2015","unstructured":"Schaapveld M, Aleman BM, van Eggermond AM et al (2015) Second cancer risk up to 40\u00a0years after treatment for hodgkin\u2019s lymphoma. N Engl J Med 373:2499\u20132511","journal-title":"N Engl J Med"},{"key":"929_CR20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ijc.2910630304","volume":"63","author":"M Andersson","year":"1995","unstructured":"Andersson M, Wallin H, Jonsson M et al (1995) Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: incidence, histology and p53 status. Int J Cancer 63:330\u2013336","journal-title":"Int J Cancer"},{"key":"929_CR21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1667\/RR3095","volume":"160","author":"LB Travis","year":"2003","unstructured":"Travis LB, Hauptmann M, Gaul LK et al (2003) Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiat Res 160:691\u2013706","journal-title":"Radiat Res"},{"key":"929_CR22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509","journal-title":"J Am Stat Assoc"},{"key":"929_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semradonc.2009.09.002","volume":"20","author":"AK Ng","year":"2010","unstructured":"Ng AK, Kenney LB, Gilbert ES, Travis LB (2010) Secondary malignancies across the age spectrum. Semin Radiat Oncol 20:67\u201378","journal-title":"Semin Radiat Oncol"},{"key":"929_CR24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/asheducation-2011.1.323","volume":"2011","author":"DC Hodgson","year":"2011","unstructured":"Hodgson DC (2011) Late effects in the era of modern therapy for Hodgkin lymphoma. Am Soc Hematol 2011:323\u2013329","journal-title":"Am Soc Hematol"},{"key":"929_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge T, Specht L, Yahalom J et al (2014) Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89:49\u201358","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht L, Yahalom J, Illidge T et al (2014) Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys 89:854\u2013862","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom J, Illidge T, Specht L et al (2015) Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92:11\u201331","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/asheducation-2013.1.400","volume":"2013","author":"PW Johnson","year":"2013","unstructured":"Johnson PW (2013) Management of early-stage Hodgkin lymphoma: is there still a role for radiation? Hematology. Am Soc Hematol 2013:400\u2013405","journal-title":"Am Soc Hematol"},{"key":"929_CR29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.6004\/jnccn.2015.0075","volume":"13","author":"RT Hoppe","year":"2015","unstructured":"Hoppe RT, Advani RH, Ai WZ et al (2015) Hodgkin lymphoma, version 2.2015. J Natl Compr Cancer Netw 13:554\u2013586","journal-title":"J Natl Compr Cancer Netw"},{"key":"929_CR30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2214\/ajr.123.3.471","volume":"123","author":"DS Wong","year":"1975","unstructured":"Wong DS, Fuller LM, Butler JJ, Shullenberger CC (1975) Extranodal non-Hodgkin\u2019s lymphomas of the head and neck. Am J Roentgenol Radium Ther Nucl Med 123:471\u2013481","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"929_CR31","first-page":"718","volume":"34","author":"BP Lanphear","year":"1992","unstructured":"Lanphear BP, Buncher CR (1992) Latent period for malignant mesothelioma of occupational origin. J Occup Med 34:718\u2013721","journal-title":"J Occup Med"},{"key":"929_CR32","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/jnci\/djs360","volume":"104","author":"SA Kovalchik","year":"2012","unstructured":"Kovalchik SA, Pfeiffer RM (2012) Re: assessment of impact of outmigration on incidence of second primary neoplasms in childhood cancer survivors estimated from SEER data. J Natl Cancer Inst 104:1517\u20131518","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0929-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0929-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0929-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T03:09:27Z","timestamp":1502248167000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0929-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0929-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]}}}